Wolter Ten Hoeve

Title: Wolter Ten Hoeve: Innovator in Bio-Orthogonal Drug Activation

Introduction

Wolter Ten Hoeve, based in Assen, Netherlands, is a prominent inventor with a remarkable portfolio of 22 patents. His contributions to the field of bio-orthogonal drug activation have significantly advanced therapeutic methodologies.

Latest Patents

Among his latest innovations are two noteworthy patents: “Cleavable tetrazine used in bio-orthogonal drug activation” and advancements related to Prodrug activation methods. The first patent describes a method using a diene as a chemically cleavable group attached to a Construct, allowing for the release of the Construct through a reaction with a dienophile capable of undergoing an inverse electron demand Diels Alder reaction. This invention also includes a kit designed for releasing a Construct bound to a Trigger, utilizing a tetrazine and a dienophile.

The second patent focuses on a Prodrug activation method that leverages abiotic reactive chemical groups with bio-orthogonal reactivity. It also details a Prodrug kit containing at least one Prodrug with a Drug and a Trigger, as well as an Activator with a second Bio-orthogonal Reactive Group. This innovation is particularly relevant to the development of targeted therapeutics, including antibody-drug conjugates and bi- and trispecific antibody derivatives.

Career Highlights

Wolter Ten Hoeve has held positions in respected organizations, including Tagworks Pharmaceuticals B.V. and Koninklijke Philips Corporation N.V. His work at these companies has allowed him to apply his innovative research and patent-focused skills in impactful ways.

Collaborations

Throughout his career, Ten Hoeve has collaborated with notable professionals in the field, including Marc Stefan Robillard and Hendricus Marie Janssen. These partnerships have fostered an environment of collaboration and innovation, contributing to advancements in drug activation techniques.

Conclusion

Wolter Ten Hoeve has made significant strides in the realm of bio-orthogonal drug activation, with a strong patent portfolio reflecting his commitment to innovation. His contributions continue to influence the development of targeted therapies, showcasing the vital role of inventors in advancing healthcare technologies.